Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer.

European journal of cancer (Oxford, England : 1990)·2025

Same author

Magnetic resonance spectroscopy - its added value in brain glioma multiparametric assessment.

Bratislavske lekarske listy·2021

Same author

Differential Urinary Proteomic Analysis of Endometrial Cancer.

Physiological research·2020

Same author

Environmental estrogen bisphenol A and autoimmunity.

Lupus·2015

Same author

[Prevalence of hyponatremia in patients on department of internal medicine].

Vnitrni lekarstvi·2013

Same author

Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literature.

Ceskoslovenska patologie·2012

Search research articles

Related Experiment Video

Updated: Nov 8, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Occurrence of two histopathologically different malignancies.

J Tokarčík, D Slížová, I Andrašina

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti

|April 28, 2021

Summary

Synchronous primary malignancies involve multiple distinct cancers in one patient. Early detection through consistent screening is crucial for better treatment outcomes in these rare cases.

Keywords:

hepatocellular carcinoma prostate cancer prostatic carcinoma sorafenib synchronous malignancies

More Related Videos

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Published on: January 26, 2024

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Nov 8, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Published on: January 26, 2024

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Area of Science:

Oncology
Clinical Medicine

Background:

Synchronous primary malignancies are defined as two or more distinct cancers in a single patient.
Reports of synchronous primary malignancies involving hepatocellular carcinoma are notably infrequent in medical literature.

Observation:

This case study details the disease progression in a 71-year-old patient presenting with two histopathologically different synchronous primary malignancies.
The patient's clinical course highlights the complexities associated with managing multiple distinct cancers simultaneously.

Findings:

The case underscores the importance of recognizing and diagnosing multiple primary tumors.
Understanding the specific clinicopathological characteristics of each synchronous malignancy is vital for effective management.

Implications:

Consistent and thorough patient screening can lead to the early detection of individual tumors.
A comprehensive understanding of clinicopathological properties and prognostic factors is essential for optimizing treatment strategies in patients with synchronous malignancies.